Tracey Fletcher, chief executive of East Kent Hospitals University Foundation Trust, has resigned after an independent investigation cleared her entirely of misconduct and found that her suspension had been handled improperly by the trust's board chair. She leaves a post she was formally vindicated in holding, after a boardroom dispute that exposed significant failings in the trust's governance.

The sequence of events began on 18 November, when chair Annette Doherty confronted Fletcher during what had been scheduled as a routine performance review. Doherty presented her with an ultimatum: accept a mutual severance settlement within 24 hours or face suspension. Fletcher declined. Three days later she was formally suspended, a decision that left one of the largest acute hospital groups in the south-east without its chief executive and caught senior leaders inside the organisation by surprise. Fletcher filed a formal grievance in December, contesting both the process and the substance of what had been put to her.

The independent investigation, conducted by a specialist human resources consultancy, found comprehensively in Fletcher's favour. It concluded that Doherty had acted in a manner "not in line with NHS values and expectations of a senior leader" and had exceeded her authority in forcing the suspension through. Fletcher was cleared of any professional wrongdoing. The process itself was found to be structurally flawed. In practical terms, the investigation confirmed that there was no legitimate basis for what had been done to her.

That she has chosen to resign despite that outcome says something about the environment she would have been returning to. A chief executive who has been publicly suspended, then publicly cleared, goes back into an organisation where the circumstances of her removal remain unresolved and where the person who initiated that removal remains in post. For Fletcher, the calculation appears to have been that the vindication on paper did not make the situation workable in practice.

East Kent Hospitals is not an organisation that can easily absorb this kind of disruption. It has been under sustained regulatory scrutiny following the findings of the independent Kirkup review in 2022, which identified serious and systemic failures in maternity care that contributed to avoidable deaths over more than a decade. The trust has been in the process of rebuilding its governance and clinical leadership since then, a process that requires exactly the kind of stable executive oversight it no longer has. Losing a chief executive under these circumstances, regardless of the investigation's findings, creates an additional layer of instability that the organisation did not need.

The impact on staff is harder to quantify but unlikely to be minor. A high-profile boardroom dispute of this kind, played out over several months and ending with the departure of a cleared executive, erodes confidence in the trust's leadership structures. Clinical staff who are already working through the aftermath of the Kirkup findings will have watched this unfold. What it tells them about how the organisation is run at the top is not a reassuring message.

NHS England's regional directors are expected to take a close interest in what happens next at East Kent. The governance failure identified in the investigation is not an internal matter that can be contained within the trust's own processes. A board chair who has been found to have exceeded her authority in removing a chief executive now faces serious questions about her own position, and it is difficult to see how those questions can be answered without external scrutiny.

In the immediate term, the trust needs interim leadership capable of maintaining operational stability while a permanent appointment is sought. That search will take place under conditions that are unlikely to make the role straightforwardly attractive. Finding and retaining capable senior executives in the NHS is already difficult; doing so at a trust carrying this level of governance baggage is harder still.

Doherty has not publicly commented on the investigation's findings. The trust has not confirmed what steps, if any, are being taken in response to the conclusion that its chair acted improperly.